Atrioventricular block following lacosamide intoxication

Epilepsy and Behavior

Volumn 20, Issue 4, 2011, Pages 725-727

  Krause, Lars U ^a   Brodowski, Kai O ^a   Kellinghaus, Christoph ^a  

^a Andreas Bannowsky Ltd   (Germany)

Author keywords

Cardiac side effect; Intravenous; Lacosamide; Status epilepticus

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; HARKOSERIDE; LORAZEPAM; TOPIRAMATE; VALPROIC ACID;

AGED; ANTICONVULSANT THERAPY; ARTICLE; ASYSTOLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; COMPLETE HEART BLOCK; DRUG INTOXICATION; DRUG MEGADOSE; ECG ABNORMALITY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HUMAN; KIDNEY DYSFUNCTION; MEDICATION ERROR; PALLIATIVE THERAPY; PR INTERVAL; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE;

ACETAMIDES; AGED, 80 AND OVER; ANTIBODIES; ANTICONVULSANTS; ATRIOVENTRICULAR BLOCK; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 79954583589     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.02.006     Document Type: Article

References (12)

1. Kellinghaus C. Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety. Ther Clin Risk Manag 2009, 5:757-766.
2. Kellinghaus C., Berning S., Immisch I., et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2011, 123:137-141.
3. Matsuo F., Bergen D., Faught E., Messenheimer J.A., Dren A.T., Rudd G.D. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993, 43:2284-2291.
4. Laville M.A., de la Gastine B., Husson B., Le Boisselier R., Mosquet B., Coquerel A. Should we care about pregabalin for elderly patients with a history of cardiac dysrhythmia?. Rev Med Intern 2008, 29:152-154.
5. Kennebäck G., Bergfeldt L., Vallin H., Tomson T., Edhag O. Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system. Am Heart J 1991, 121:1421-1429.
6. Ben Menachem E., Biton V., Jatuzis D., Abou-Khalil B., Doty P., Rudd G.D. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007, 48:1308-1317.
7. Chung S., Sperling M., Biton V., et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 2010, 51:958-967. for the SP754 Study Group.
8. Halasz P., Kalviainen R., Mazurkiewicz-Beldzinska M., et al. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 2009, 50:443-453.
9. Degiorgio C.M. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures. Epilepsy Behav 2010, 18:322-324.
10. Prystowsky E.N. The effects of slow channel blockers and beta blockers on atrioventricular nodal conduction. J Clin Pharmacol 1988, 28:6-21.
11. Dunlap E.D., Plowden J.S., Lathrop D.A., Millard R.W. Hemodynamic and electrophysiologic effects of amlodipine, a new calcium channel blocker. Am J Cardiol 1989, 64:71-77.
12. Ruiz-Ceretti E., Ponce Zumino A. Atrioventricular block in low potassium and K dependence of the nodal resting potential. Can J Physiol Pharmacol 1986, 64:531-538.